(Adds Outlook, Non-GAAP Earnings)
While reporting its results for the second quarter, Gilead Sciences Inc. (GILD) revised its outlook for the full-year 2024.
The company now expects earnings of breakeven per share to $0.30 per share and adjusted earnings of $3.60 to $3.90 per share. Previously, the company expected earnings of $0.10 to $0.50 per share and adjusted earnings of $3.45 to $3.85 per share.
Analysts polled by Thomson Reuters currently expect earnings of $3.75 per share.
Q2 Results:
The company's bottom line totaled $1.614 billion or $1.29 per share. This compares with $1.045 billion, or $0.83 per share, in last year's second quarter.
Adjusted earnings for the quarter were $2.01 per share, compared to $1.34 per share last year. Analysts on average had expected the company to earn $1.60 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 5.4% to $6.954 billion from $6.599 billion last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.